Interstitial Lung Disease clinical trials at UCSD
1 in progress, 0 open to eligible people
Showing trials for
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Sorry, not currently recruiting here
Study RIN-PF-301 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with idiopathic pulmonary fibrosis (IPF) over a 52-week period.
La Jolla, California and other locations
Our lead scientists for Interstitial Lung Disease research studies include Gordon Yung, MD.
Last updated: